Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?

International Journal of Cancer

Volumn 129, Issue 10, 2011, Pages 2310-2314

  Scheel, Christina ^a   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

cancer stem cells; cellular state; epithelial mesenchymal transition; multi step progression; phenotypic plasticity; self renewal; stem cells; tumor initiating ability

Indexed keywords

IMATINIB;

ARTICLE; CANCER GROWTH; CANCER STEM CELL; CELL COMPARTMENTALIZATION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STEM CELL; TUMOR GROWTH;

DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; HOMEOSTASIS; HUMANS; NEOPLASTIC STEM CELLS; PHENOTYPE; STEM CELLS;

EID: 80052964920     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26311     Document Type: Article

References (43)

1. Shackleton M, Quintana E, Fearon ER, Morrison SJ,. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009; 138: 822-9.
2. Marotta LL, Polyak K,. Cancer stem cells: a model in the making. Curr Opin Genet Dev 2009; 19: 44-50.
3. Alison MR, Lim SM, Nicholson LJ,. Cancer stem cells: problems for therapy? J Pathol 2011; 223: 147-61.
4. O'Brien CA, Kreso A, Jamieson CH,. Cancer stem cells and self-renewal. Clin Cancer Res 2010; 16: 3113-20.
5. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE,. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-8. (Pubitemid 24067706)
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF,. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-8. (Pubitemid 36418143)
7. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB,. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401. (Pubitemid 39551674)
8. O'Brien CA, Pollett A, Gallinger S, Dick JE,. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-10. (Pubitemid 46067310)
9. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R,. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-5. (Pubitemid 46067311)
10. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C,. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-23. (Pubitemid 47355323)
11. Kennedy JA, Barabe F, Poeppl AG, Wang JC, Dick JE,. Comment on "Tumor growth need not be driven by rare cancer stem cells". Science 2007; 318: 1722; author reply
12. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ,. Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-8.
13. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG, Di Fiore PP,. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010; 140: 62-73.
14. Nowell PC,. The clonal evolution of tumor cell populations. Science 1976; 194: 23-8.
15. Cho KR, Vogelstein B,. Genetic alterations in the adenoma - carcinoma sequence. Cancer 1992; 70: 1727-31.
16. Meyerson M, Gabriel S, Getz G,. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010; 11: 685-96.
17. Drake JW, Charlesworth B, Charlesworth D, Crow JF,. Rates of spontaneous mutation. Genetics 1998; 148: 1667-86. (Pubitemid 28180696)
18. Elez M, Murray AW, Bi LJ, Zhang XE, Matic I, Radman M,. Seeing mutations in living cells. Curr Biol 2010; 20: 1432-7.
19. Cotsarelis G, Sun TT, Lavker RM,. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990; 61: 1329-37.
20. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T,. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-61. (Pubitemid 38962572)
21. Loeb LA, Cheng KC,. Errors in DNA synthesis: a source of spontaneous mutations. Mutat Res 1990; 238: 297-304.
22. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H,. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-7. (Pubitemid 350014593)
23. Li L, Clevers H,. Coexistence of quiescent and active adult stem cells in mammals. Science 2010; 327: 542-5.
24. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-15. (Pubitemid 351636299)
25. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A,. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008; 3: e2888.
26. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA,. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009; 119: 1438-49.
27. Thiery JP, Acloque H, Huang RY, Nieto MA,. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-90.
28. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009; 138: 592-603.
29. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11: 1487-95.
30. Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, Chang SY, Lee OK, et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010; 12: 982-92.
31. Singh A, Settleman J,. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29: 4741-51.
32. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T,. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5: 744-9. (Pubitemid 41486367)
33. Kirchner T, Brabletz T,. Tumor patterning: analogies of neoplastic morphogenesis with embryogenesis. Verh Dtsch Ges Pathol 2000; 84: 22-7.
34. Giehl K, Menke A,. Microenvironmental regulation of E-cadherin-mediated adherens junctions. Front Biosci 2008; 13: 3975-85. (Pubitemid 351594675)
35. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ,. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10: 295-305.
36. Diehn M, Cho RW, Clarke MF,. Therapeutic implications of the cancer stem cell hypothesis. Semin Radiat Oncol 2009; 19: 78-86.
37. Rice KN, Jamieson CH,. Molecular pathways to CML stem cells. Int J Hematol 2010; 91: 748-52.
38. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES,. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138: 645-59.
39. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, Munchhof M, VanArsdale T, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458: 776-9.
40. Bomken S, Fiser K, Heidenreich O, Vormoor J,. Understanding the cancer stem cell. Br J Cancer 2010; 103: 439-45.
41. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, Wong KK, Brandstetter K, et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010; 141: 69-80.
42. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M,. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141: 583-94.
43. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM, Morrison SJ,. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010; 18: 510-23.